Investigation of the Longevity of the Endoscopic Midface Lift.

Q1 Medicine
Julie P. Shtraks, C. Fundakowski, Daohai Yu, M. Hartstein, David Sarcu, Xiaoning Lu, A. Wulc
{"title":"Investigation of the Longevity of the Endoscopic Midface Lift.","authors":"Julie P. Shtraks, C. Fundakowski, Daohai Yu, M. Hartstein, David Sarcu, Xiaoning Lu, A. Wulc","doi":"10.1001/jamafacial.2019.1015","DOIUrl":null,"url":null,"abstract":"Importance\nTo our knowledge, until now, the efficacy and durability of the transtemporal endoscopic preperiosteal midface lift has not been reported in the literature.\n\n\nObjective\nTo determine the efficacy and longevity of the endoscopic preperiosteal midface lift using objective measurements and validated aesthetic scales.\n\n\nDesign, Setting, and Participants\nThis retrospective review included patients 18 years or older who were treated for aging midface by endoscopic midface lift by the senior author (A.E.W.) between June 2000 and August 2016. Patients were categorized based on length of follow-up into 3 groups: (1) short-term (1-3 years), (2) intermediate-term (3-5 years), and (3) long-term (>5 years).\n\n\nInterventions or Exposures\nEndoscopic preperiosteal midface lift.\n\n\nMain Outcomes and Measures\n(1) Objective measurements of midfacial height (the width of the interzygomatic distance of the midface to the medial canthus [WIZDOM-MC]), (2) validated regional aesthetic scales, and (3) global aesthetic scoring systems measured preoperatively, 3 to 6 months postoperatively, and at the most recent follow-up visit.\n\n\nResults\nAdult patients 18 years or older (median [range] age, 59 [31-79] years) who were treated for aging midface by undergoing an endoscopic midface lift were included in this study. The medical records of 143 patients were reviewed (135 women and 8 men). The endoscopic midface lift resulted in objective improvement in midfacial height. The median WIZDOM-MC decreased by 3.4 mm after the endoscopic midface lift (interquartile range [IQR], 2.3-4.4 mm; P < .001), thus shortening the elongated lower eyelid. At 5 to 15 years after surgery, there was a sustained decrease in median WIZDOM-MC of 2.1 mm (IQR, 0.8-3.1 mm; P < .001). Improvement in the infraorbital hollow was also sustained in patients at more than 5 years' follow-up (IQR, 0-1.0; P < .001). Improvements in upper cheek fullness and lower cheek fullness were maintained at 3 to 5 years and tended to be at baseline at more than 5 years. Global aesthetic improvement scores remained significantly improved at 5 to 15 years' follow-up.\n\n\nConclusions and Relevance\nThere is a significant, objective improvement in midfacial height after the endoscopic midface lift that persists for up to 15 years. Validated midfacial scales and global aesthetic scoring systems demonstrate sustained improvement in midface appearance over time. Surgery that minimally disrupts the zygomatic and orbicularis retaining ligaments can provide long-lasting aesthetic improvements.\n\n\nLevel of Evidence\n4.","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2019.1015","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA facial plastic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/jamafacial.2019.1015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 7

Abstract

Importance To our knowledge, until now, the efficacy and durability of the transtemporal endoscopic preperiosteal midface lift has not been reported in the literature. Objective To determine the efficacy and longevity of the endoscopic preperiosteal midface lift using objective measurements and validated aesthetic scales. Design, Setting, and Participants This retrospective review included patients 18 years or older who were treated for aging midface by endoscopic midface lift by the senior author (A.E.W.) between June 2000 and August 2016. Patients were categorized based on length of follow-up into 3 groups: (1) short-term (1-3 years), (2) intermediate-term (3-5 years), and (3) long-term (>5 years). Interventions or Exposures Endoscopic preperiosteal midface lift. Main Outcomes and Measures (1) Objective measurements of midfacial height (the width of the interzygomatic distance of the midface to the medial canthus [WIZDOM-MC]), (2) validated regional aesthetic scales, and (3) global aesthetic scoring systems measured preoperatively, 3 to 6 months postoperatively, and at the most recent follow-up visit. Results Adult patients 18 years or older (median [range] age, 59 [31-79] years) who were treated for aging midface by undergoing an endoscopic midface lift were included in this study. The medical records of 143 patients were reviewed (135 women and 8 men). The endoscopic midface lift resulted in objective improvement in midfacial height. The median WIZDOM-MC decreased by 3.4 mm after the endoscopic midface lift (interquartile range [IQR], 2.3-4.4 mm; P < .001), thus shortening the elongated lower eyelid. At 5 to 15 years after surgery, there was a sustained decrease in median WIZDOM-MC of 2.1 mm (IQR, 0.8-3.1 mm; P < .001). Improvement in the infraorbital hollow was also sustained in patients at more than 5 years' follow-up (IQR, 0-1.0; P < .001). Improvements in upper cheek fullness and lower cheek fullness were maintained at 3 to 5 years and tended to be at baseline at more than 5 years. Global aesthetic improvement scores remained significantly improved at 5 to 15 years' follow-up. Conclusions and Relevance There is a significant, objective improvement in midfacial height after the endoscopic midface lift that persists for up to 15 years. Validated midfacial scales and global aesthetic scoring systems demonstrate sustained improvement in midface appearance over time. Surgery that minimally disrupts the zygomatic and orbicularis retaining ligaments can provide long-lasting aesthetic improvements. Level of Evidence 4.
内窥镜下面部除皱术的使用寿命研究。
重要性据我们所知,到目前为止,经颞内窥镜骨膜前面中部提拉术的疗效和耐用性尚未在文献中报道。目的通过客观测量和经验证的美学量表来确定内镜下骨膜前面中部提拉术的疗效和使用寿命。设计、设置和参与者这项回顾性综述包括在2000年6月至2016年8月期间由资深作者(A.E.W.)通过内窥镜面部中部提拉术治疗面部衰老的18岁或以上患者。根据随访时间将患者分为3组:(1)短期(1-3年)、(2)中期(3-5年)和(3)长期(>5年)。主要结果和测量(1)面中部高度的客观测量(面中部至内眼角颧骨间距离的宽度[WIZDOM-MC]),(2)经验证的区域美学量表,以及(3)术前、术后3-6个月和最近随访时测量的整体美学评分系统。结果本研究纳入了18岁或18岁以上(中位[范围]年龄,59[31-79]岁)的成人患者,他们通过接受内镜下面中部提升术治疗面中部衰老。对143名患者(135名女性和8名男性)的医疗记录进行了审查。内窥镜下的面中部抬高术客观上改善了面中部的高度。内窥镜面中部提拉术后WIZDOM-MC中位数下降3.4 mm(四分位间距[IQR],2.3-4.4 mm;P < .001),从而缩短细长的下眼睑。术后5至15年,WIZDOM-MC中位数持续下降2.1 mm(IQR,0.8-3.1 mm;P < .001)。在5年以上的随访中,患者的眶下凹陷也得到了持续改善(IQR,0-1.0;P < .001)。上脸颊丰满度和下脸颊丰满度的改善在3至5年时保持,并且在5年以上时趋于基线。在5至15年的随访中,整体美学改善评分仍有显著改善。结论和相关性内窥镜面部中部抬高术后,面部中部高度有显著、客观的改善,这种改善持续了15年。经过验证的中场尺度和全球美学评分系统表明,随着时间的推移,中场表现持续改善。将颧骨和轮匝肌保留韧带的破坏降至最低的手术可以提供持久的美学改善。证据级别4。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
0
期刊介绍: Facial Plastic Surgery & Aesthetic Medicine (Formerly, JAMA Facial Plastic Surgery) is a multispecialty journal with a key mission to provide physicians and providers with the most accurate and innovative information in the discipline of facial plastic (reconstructive and cosmetic) interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信